Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 14;191(3):135.
doi: 10.1007/s00604-024-06207-5.

Development of a Cr2AlC MAX phase/g-C3N4 composite-based electrochemical sensor for accurate cabotegravir determination in pharmaceutical and biological samples

Wiem Bouali  1   2 , Asena Ayse Genc  3   4 , Nevin Erk  5 , Gul Kaya  6 , Buse Sert  6 , Kasim Ocakoglu  6
Affiliations

Development of a Cr2AlC MAX phase/g-C3N4 composite-based electrochemical sensor for accurate cabotegravir determination in pharmaceutical and biological samples

Wiem Bouali et al. Mikrochim Acta. .

Abstract

A highly sensitive electrochemical sensor is reported that employs a modified electrode for the precise measurement of cabotegravir, a potent anti-HIV drug. Cyclic voltammetry (CV), differential pulse voltammetry (DPV), and electrochemical impedance spectroscopy (EIS) were utilized for this purpose. Electrode modification involved the immobilization of Cr2AlC MAX phase/g-C3N4 onto a glassy carbon electrode (GCE) to enhance its electrocatalytic activity and selectivity for cabotegravir detection. Under the optimal experimental conditions, the working potential (vs. Ag/AgCl) was to 0.93 V. The developed sensor exhibited a good linear relationship in the range 0.05 µM to 9.34 µM with a low limit of detection of 4.33 nM, signifying its exceptional sensitivity. Additionally, it demonstrated successful cabotegravir detection in pharmaceutical formulations and biological samples, achieving an RSD below 3.0%. The recoveries fell within the range 97.7 to 102%, confirming the sensor's potential for real-sample applications. This innovative electrochemical sensor represents a significant advancement, providing a simple, reliable, and sensitive tool for the accurate measurement of cabotegravir. Its potential applications include optimizing drug dosages, monitoring treatment responses, and supporting the development of cabotegravir-based pharmaceutical products, thereby contributing to advancements in HIV therapy and prevention strategies.

Keywords: Cabotegravir; Cr2AlC MAX phase; Differential pulse voltammetry; Electrochemical sensor; Modified glassy carbon electrode; Pharmaceutical products; g-C3N4.

PubMed Disclaimer

References

    1. Han Y, Mesplède T, Wainberg M (2015) Cabotegravir. HIV integrase inhibitor, anti-HIV agent. Drugs Future 40(11). https://doi.org/10.1358/dof.2015.040.11.2383040
    1. Taki E, Soleimani F, Asadi A et al (2022) Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV. Expert Rev Anti Infect Ther 20:1135–1147. https://doi.org/10.1080/14787210.2022.2081153 - DOI - PubMed
    1. Prasanna A, Rani SS (2022) A Validated Stability Indicating RP-HPLC Method Development for Simultaneous estimation of Cabotegravir and Rilpivirine in Pharmaceutical Dosage form. World J Pharm Sci 22–29. https://doi.org/10.54037/WJPS.2022.101003
    1. Blair HA (2022) Cabotegravir extended-release injectable suspension: A review in HIV-1 pre-exposure prophylaxis. Drugs 82:1489–1498. https://doi.org/10.1007/s40265-022-01791-3 - DOI - PubMed
    1. Enggi CK, Isa HT, Wijaya S et al (2022) Validation of spectrophotometric method to quantify cabotegravir in simulated vaginal fluid and porcine vaginal tissue in ex vivo permeation and retention studies from thermosensitive and mucoadhesive gels. Spectrochim Acta Part A Mol Biomol Spectrosc 267:120600. https://doi.org/10.1016/j.saa.2021.120600 - DOI

Publication types